Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Idera Pharmaceuticals Inc.

TRADE

NASDAQ: IDRAHealthcare / Biotechnology / USA
0.86-0.01-1.15%Vol 1 484 8681Y Perf -54.74%
Jul 20th, 2018 16:00
BID0.86 ASK0.86
Open0.88 Previous Close0.87
Pre-Market0.87 After-Trading0.86
 - -%  - -%
Target Price
4.25 
Analyst Rating
Strong Buy 1.00
Potencial %
394.19 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★★★     58.12
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)187 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
2.90 
Earnings Date
6th Aug 2018

Today's Price Range

0.830.89

 

52wk Range

0.802.87

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Month
-41.50%
3 Months
-46.91%
6 Months
-66.27%
1 Year
-54.74%
3 Years
-76.31%
5 Years
7.50%

Quotes

Name / TickerPriceChg.Chg.%
IDRA0.86-0.0100-1.15
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 8.70
Current Ratio 8.90
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -1 731.20
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-9 111.80
EBITDA Margin-9 016.90
Pre-tax Profit Margin-23 753.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.22
PS Ratios 370.75
Price to Cash Flow 6.00
Price to Free Cash Flow -5.70
Cash Flow Per Share -0.31
Price to Tangible Book2.22
Book Value per Share0.46
Enterprise Value (in ths.)112 156
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-68.00
ROE last 12 Months -69.88
Return on Assets (5Y Avg) -40.37
ROA last 12 Months -63.22
Return on Capital (5Y Avg) -105.22
ROC last 12 Months -75.58
Return on invested Capital Q -19.62
Return on invested Capital Y-62.88
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)592
Revenue per Share 0.00
Revenue Growth 3 Years 129.90
Revenue Growth 5 Years 135.69
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.09-0.10-11.11
Q04 2017-0.08-0.080.00
Q03 2017-0.12-0.1016.67
Q02 2017-0.11-0.14-27.27
Q01 2017-0.10-0.100.00
Q04 2016-0.110.01109.09
Q03 2016-0.11-0.109.09
Q02 2016-0.11-0.110.00
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.10-11.11Negative
9/2018 QR-0.100.00-
12/2018 FY-0.39-5.41Negative
12/2019 FY-0.43-2.38Negative
Next Report Date6th Aug 2018
Estimated EPS Next Report-0.10
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume1 484 868
Shares Outstanding (in ths.)217 310
Trades Count3 451
Dollar Volume1 163 679
Avg. Volume1 738 579
Avg. Weekly Volume3 178 406
Avg. Monthly Volume2 307 667
Avg. Quarterly Volume1 792 251

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

64%36%

Bearish Bullish

52%48%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x